Business Wire
BusinessFTC issues civil subpoenas to OpenAI and Anthropic in consumer-protection probe, spotlighting regulatory risk for Microsoft and other major AI backersThe Apex TimesBusinessSkydance steadies after merger-era drop, Disney firms and Netflix eases lower in afternoon tradingThe Apex TimesBusinessBlackRock files a bitcoin ETF structure aimed at limiting losses and capping gains using optionsThe Apex TimesBusinessModerna shares jump 7% as melanoma vaccine data in Madrid draws attention; Bristol Myers and Pfizer also edge higherThe Apex TimesBusinessChevron seeks stake shift in Iraq oil field tied to Russian influence, as U.S. pressures the status quoThe Apex TimesBusinessCaterpillar vs. Deere in the data-center buildout debate: what investors are weighingThe Apex TimesBusinessBraze shares surge after Salesforce agrees to buy the marketing software company for $47The Apex TimesBusinessAlaska Airlines names CVS Health executive for newly created technology and AI roleThe Apex TimesBusinessEli Lilly’s pediatric ulcerative colitis trial results put Omvoh back in focus for investors, but full details remain limitedThe Apex TimesBusinessGeneral Motors shares fall about 6% even after a reported earnings beat, as investors focus on the narrower outlook rangeThe Apex TimesBusinessWalmart ties Walmart+ and Sam’s Club into a single $120-a-year membership bundleThe Apex TimesBusinessBoeing and Microsoft collaboration on an AI “dataliner” platform draws analyst attention, lifting BMO’s Microsoft targetThe Apex TimesBusinessFTC issues civil subpoenas to OpenAI and Anthropic in consumer-protection probe, spotlighting regulatory risk for Microsoft and other major AI backersThe Apex TimesBusinessSkydance steadies after merger-era drop, Disney firms and Netflix eases lower in afternoon tradingThe Apex TimesBusinessBlackRock files a bitcoin ETF structure aimed at limiting losses and capping gains using optionsThe Apex TimesBusinessModerna shares jump 7% as melanoma vaccine data in Madrid draws attention; Bristol Myers and Pfizer also edge higherThe Apex TimesBusinessChevron seeks stake shift in Iraq oil field tied to Russian influence, as U.S. pressures the status quoThe Apex TimesBusinessCaterpillar vs. Deere in the data-center buildout debate: what investors are weighingThe Apex TimesBusinessBraze shares surge after Salesforce agrees to buy the marketing software company for $47The Apex TimesBusinessAlaska Airlines names CVS Health executive for newly created technology and AI roleThe Apex TimesBusinessEli Lilly’s pediatric ulcerative colitis trial results put Omvoh back in focus for investors, but full details remain limitedThe Apex TimesBusinessGeneral Motors shares fall about 6% even after a reported earnings beat, as investors focus on the narrower outlook rangeThe Apex TimesBusinessWalmart ties Walmart+ and Sam’s Club into a single $120-a-year membership bundleThe Apex TimesBusinessBoeing and Microsoft collaboration on an AI “dataliner” platform draws analyst attention, lifting BMO’s Microsoft targetThe Apex TimesBusinessFTC issues civil subpoenas to OpenAI and Anthropic in consumer-protection probe, spotlighting regulatory risk for Microsoft and other major AI backersThe Apex TimesBusinessSkydance steadies after merger-era drop, Disney firms and Netflix eases lower in afternoon tradingThe Apex TimesBusinessBlackRock files a bitcoin ETF structure aimed at limiting losses and capping gains using optionsThe Apex TimesBusinessModerna shares jump 7% as melanoma vaccine data in Madrid draws attention; Bristol Myers and Pfizer also edge higherThe Apex TimesBusinessChevron seeks stake shift in Iraq oil field tied to Russian influence, as U.S. pressures the status quoThe Apex TimesBusinessCaterpillar vs. Deere in the data-center buildout debate: what investors are weighingThe Apex TimesBusinessBraze shares surge after Salesforce agrees to buy the marketing software company for $47The Apex TimesBusinessAlaska Airlines names CVS Health executive for newly created technology and AI roleThe Apex TimesBusinessEli Lilly’s pediatric ulcerative colitis trial results put Omvoh back in focus for investors, but full details remain limitedThe Apex TimesBusinessGeneral Motors shares fall about 6% even after a reported earnings beat, as investors focus on the narrower outlook rangeThe Apex TimesBusinessWalmart ties Walmart+ and Sam’s Club into a single $120-a-year membership bundleThe Apex TimesBusinessBoeing and Microsoft collaboration on an AI “dataliner” platform draws analyst attention, lifting BMO’s Microsoft targetThe Apex TimesBusinessFTC issues civil subpoenas to OpenAI and Anthropic in consumer-protection probe, spotlighting regulatory risk for Microsoft and other major AI backersThe Apex TimesBusinessSkydance steadies after merger-era drop, Disney firms and Netflix eases lower in afternoon tradingThe Apex TimesBusinessBlackRock files a bitcoin ETF structure aimed at limiting losses and capping gains using optionsThe Apex TimesBusinessModerna shares jump 7% as melanoma vaccine data in Madrid draws attention; Bristol Myers and Pfizer also edge higherThe Apex TimesBusinessChevron seeks stake shift in Iraq oil field tied to Russian influence, as U.S. pressures the status quoThe Apex TimesBusinessCaterpillar vs. Deere in the data-center buildout debate: what investors are weighingThe Apex TimesBusinessBraze shares surge after Salesforce agrees to buy the marketing software company for $47The Apex TimesBusinessAlaska Airlines names CVS Health executive for newly created technology and AI roleThe Apex TimesBusinessEli Lilly’s pediatric ulcerative colitis trial results put Omvoh back in focus for investors, but full details remain limitedThe Apex TimesBusinessGeneral Motors shares fall about 6% even after a reported earnings beat, as investors focus on the narrower outlook rangeThe Apex TimesBusinessWalmart ties Walmart+ and Sam’s Club into a single $120-a-year membership bundleThe Apex TimesBusinessBoeing and Microsoft collaboration on an AI “dataliner” platform draws analyst attention, lifting BMO’s Microsoft targetThe Apex Times
Back to front
Berkshire Hathaway’s buyback approach keeps drawing attention, with one analyst framing it as “intrinsic value” discipline
The Apex Times

THE APEX TIMES

Business/The Apex Times/Aug 7, 10:59 AM EDT

Berkshire Hathaway’s buyback approach keeps drawing attention, with one analyst framing it as “intrinsic value” discipline

A new market commentary argues Berkshire Hathaway’s share repurchases have generally been timed to support a long-running Buffett-style test: only buy when the stock is below what the business is worth.

Berkshire Hathaway’s capital-return strategy is once again under the microscope, after a market commentary highlighted how the company has historically approached stock buybacks through what it calls an “intrinsic value” lens. The piece, published by Yahoo Finance on Aug. 7, focuses less on near-term trading and more on the framework investors may be able to borrow from Warren Buffett’s style.

In the article, the central claim is that Berkshire Hathaway’s buybacks have, in practice, been conducted when the market price offered a discount relative to the company’s estimate of intrinsic value. Intrinsic value is the idea of what a business is worth based on fundamentals like earnings power, cash flows, and growth prospects, rather than what the shares are trading for today.

The analysis is framed as a discipline lesson for individual investors: if you assume a stock has a “fair value” you can approximate, repurchases make more sense when the market price runs below that fair value estimate. The commentary suggests that the same thinking can be applied to other portfolio decisions, not just to Berkshire itself.

Importantly, the post’s emphasis is methodological rather than operational. It does not present a detailed, transaction-by-transaction buyback schedule in the information available here. As a result, readers are left to treat the “below intrinsic value” characterization as the article’s interpretation of how Berkshire has behaved over time, rather than as a set of disclosed buyback triggers published by Berkshire.

Berkshire’s role in this discussion matters because buybacks are one of the few shareholder-return tools it can deploy without needing to change its operating strategy. When a company repurchases shares, it effectively reallocates cash from the balance sheet to existing owners, which can support per-share metrics if the repurchase price is favorable and the company continues to generate cash.

Still, Berkshire’s broader investment culture includes a heavy focus on fundamental valuation and long-term compounding, which tends to shape how investors interpret its buybacks. Even when buybacks are not the company’s most visible lever, they can announcement management’s view of whether the market is pricing the business conservatively or aggressively relative to fundamentals.

One caveat for readers is that the specific evidence behind the “only bought back below intrinsic value” framing is not visible in the limited materials available for this review. Without the post’s underlying data, tables, or cited Berkshire documents in view, it is not possible to independently verify the degree of discount, the exact timing of buyback periods, or how the intrinsic value estimate was constructed in the commentary.

What to watch next, if you are tracking Berkshire Hathaway from an investor-discipline standpoint, is whether future buyback commentary continues to connect repurchase timing to valuation gaps in a measurable way. For outside investors, the more actionable takeaway may be less about copying Berkshire’s exact mechanics and more about insisting on a clear valuation yardstick before making decisions that involve paying a market price for corporate earnings.

Why It Matters

  • The way Berkshire times buybacks can influence how investors interpret its capital allocation and valuation discipline.
  • Intrinsic-value framing, if supported with data, can offer a concrete lens for deciding when repurchases are attractive.
  • If the buyback argument relies on interpretation rather than disclosed rules, it may be harder for investors to replicate precisely.

Sources

Key Facts

  • A Yahoo Finance commentary published Aug. 7, 2026 argues Berkshire Hathaway has historically bought back shares in a way consistent with repurchasing below “intrinsic value.”
  • The article frames intrinsic value as a fundamentals-based estimate of fair business worth, contrasted with the current market price.
  • The commentary positions the Berkshire example as a framework investors can apply to their own discipline, emphasizing valuation-based timing.
  • No specific buyback figures, schedules, or disclosed Berkshire repurchase triggers are included in the materials available here.

Finance Related

Oct 20, 1:14 PM EDT
The Apex Times

JPMorgan weighs the value of physical branches as banks compete for higher-value customers

A new stock-market analysis highlights JPMorgan Chase’s continued branch expansion, arguing that in-person presence can help win and retain customers who generate deposits, investment revenue, and loan demand. But the company has not provided detailed, publicly disclosed results tying specific branch openings to profitability or customer retention.

JPMorgan weighs the value of physical branches as banks compete for higher-value customers
The Apex Times
Berkshire Hathaway’s buyback approach keeps drawing attention, with one analyst framing it as “intrinsic value” discipline | The Apex Times